Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Australian Bragg Centre for Proton Therapy and Research is the first clinically dedicated proton therapy facility in Australia and the Southern Hemisphere. Located in Adelaide's BioMed City, the center is housed within the SAHMRI 2 building and represents a significant advancement in oncology treatment for the region. The facility utilizes Varian’s ProBeam technology to deliver high-precision proton beams that target tumors while sparing adjacent healthy organs and tissues. This treatment modality is particularly critical for pediatric patients and those with tumors located near sensitive structures like the brain, spine, or heart. In addition to clinical services, the center functions as a major research hub, conducting clinical trials and collaborating with international partners to advance particle therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Australian Bragg Center for Proton Therapy and Research.